Expression of differential immune factors in temporal cortex and cerebellum: The role of α-1-antichymotrypsin, apolipoprotein E, and reactive glia in the progression of Alzheimer's disease

Journal of Comparative Neurology

Volumn 396, Issue 4, 1998, Pages 511-520

  Styren, Scot D ^a   Kamboh, M Ilyas ^a   Dekosky, Steven T ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

amyloid; Astrocytes; Diffuse plaques; Microgila; Ultrastructural

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ALZHEIMER DISEASE; ARTICLE; GENETIC SUSCEPTIBILITY; GLIOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; TEMPORAL CORTEX; ULTRASTRUCTURE;

ALPHA 1-ANTICHYMOTRYPSIN; ALZHEIMER DISEASE; APOLIPOPROTEINS E; ASTROCYTES; BIOLOGICAL MARKERS; CEREBELLUM; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, IMMUNOELECTRON; NEUROGLIA; SENILE PLAQUES; TEMPORAL LOBE;

EID: 0032514237     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9861(19980713)396:4<511::AID-CNE7>3.0.CO;2-4     Document Type: Article

References (55)

1. Abraham, C.R., D.J. Selkoe, and H. Potter (1988) Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52:487-501.
2. Altstiel, L.D., B. Lawlor, R. Mohs, J. Schmeidler, A. Dalton, P. Mehta, and K. Davis (1995) Elevated alpha-1-antichymotrypsin serum levels in a subset of nondemented first-degree relatives of Alzheimer's disease patients. Dementia 6:17-20.
3. Brachova, L., L.F. Lue, J. Schultz, T. el Rashidy, and J. Rogers (1993) Association cortex, cerebellum, and serum concentrations of C1q and factor B in Alzheimer's disease. Brain Res. Mol. Brain Res. 18:329-334.
4. Citron, M., T.S. Diehl, G. Gordon, A.L. Biere, P. Seubert, and D.J. Selkoe (1996) Evidence that the 42- and 40-amino acid forms of amyloid protein are generated from the beta-amyloid precursor protein by different protease activities. Proc. Natl. Acad. Sci. USA 93:13170-13175.
5. Coleman, P.D., A.M. Kazee, L. Lapham, T. Eskin, and K. Rogers (1992) Reduced GAP-43 message levels are associated with increased neurofibrillary tangle density in the frontal association cortex (area 9) in Alzheimer's disease. Neurobiol. Aging 13:631-639.
6. Corder, E.H., A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines, and M.A. Pericak-Vance (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923.
7. Das, S. and H. Potter (1995) Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1. Neuron 14:447-456.
8. DeKosky, S.T., C.E. Aston, and M.I. Kamboh (1996) Polygenic determinants of Alzheimer's disease: Modulation of risk by alpha 1-antichymotrypsin. Ann. N.Y. Acad. Sci. 802:27-34.
9. Dickson, D.W. (1997) The pathogenesis of senile plaques. J. Neuropathol. Exp. Neurol. 56:321-339.
10. Frautschy, S.A., F.S. Yang, M. Irrizarry, B. Hyman, T.C. Saido, K. Hsiao, and G.M. Cole (1998) Microglial response to amyloid plaques in APPSW transgenic mice. Am. J. Pathol. 152:307-317.
11. Fukumoto, H., A. Asami-Odaka, N. Suzuki, and T. Iwatsubo (1996) Association of A Beta 40 positive senile plaques with microglial cells in the brains of patients with Alzheimer's disease and in non-demented aged individuals. Neurodegeneration 5:13-17.
12. Gearing, M., J.A. Schneider, R.S. Robbins, R.D. Hollister, H. Mori, D. Games, B.T. Hyman, and S.S. Mirra (1995) Regional variation in the distribution of apolipoprotein E and A βin Alzheimer's disease. J. Neuropathol. Exp. Neurol. 54:833-841.
13. Griffin, W.S.T., L.C. Stanley, C. Ling, L. White, V. Macleod, L.J. Perrot, C.L. White, III, and C. Araoz (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer's disease. Proc. Natl. Acad. Sci. USA 86:7611-7615.
14. Haines, J.L., M.L. Pritchard, A.M. Saunders, J.M. Schildkraut, J.H. Growdon, P.C. Gaskell, L.A. Farrer, S.A. Auerbach, J.F. Gusella, P.A. Locke, B.L. Rosi, L. Yamaoka, G.W. Small, P.M. Conneally, A.D. Roses, and M.A. Pericak-Vance (1996) No genetic effect of alpha-1-antichymotrypsin in Alzheimer disease. Genomics 33:53-56.
15. Hoke, A., D.R. Canning, C.J. Malemud, and J. Silver (1994) Regional differences in reactive gliosis induced by substrate-bound beta-amyloid. Exp. Neurol. 130:56-66.
16. Iwatsubo, T., A. Odaka, N. Suzuki, H. Mizusawa, N. Nukina, and Y. Ihara (1994) Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43). Neuron 13:45-53.
17. Kalaria, R.N. and G. Perry (1993) Amyloid P component and other acute-phase proteins associated with cerebellar a beta-deposits in Alzheimer's disease. Brain Res. 631:151-155.
18. Kamboh, M.I. (1995) Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease. Hum. Biol. 67:195-215.
19. Kamboh, M.I., D.K. Sanghera, R.E. Ferrell, and S.T. DeKosky (1995) Alzheimer's disease risk associated with APOE-4 is modified by alpha 1-antichymotrypsin genetic polymorphism. Nature Genet. 10:486-488.
20. Li, Y.T., D.S. Woodruffpak, and J.Q. Trojanowski (1994) Amyloid plaques in cerebellar cortex and the integrity of Purkinje cell dendrites. Neurobiol. Aging 15:1-9.
21. Licastro, F., M.C. Morini, E. Polazzi, and L.J. Davis (1995) Increased serum alpha 1-antichymotrypsin in patients with probable Alzheimer's disease: An acute phase reactant without the peripheral acute phase response. J. Neuroimmunol. 57:71-75.
22. Ma, J., A. Yee, H.B.J. Brewer, and S. Das (1994) Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 372:92-94.
23. Mackenzie, I.R.A., C. Hao, and D.G. Munoz (1995) Role of microglia in senile plaque formation. Neurobiol. Aging 16:797-804.
24. Mann, D.M.A., T. Iwatsubo, N.J. Cairns, P.L. Lantos, D. Nochlin, S.M. Sumi, T.D. Bird, P. Poorkaj, J. Hardy, M. Hutton, G. Prihar, R. Crook, M.N. Rossor, and M. Haltia (1996) Amyloid beta protein deposition in chromosome 14-linked Alzheimer's disease: Predominance of A eta 42(43). Ann. Neurol. 40: /I149-156.
25. Matsubara, E., S. Hirai, M. Amari, M. Shoji, H. Yamaguchi, K. Okamoto, K. Ishiguro, Y. Harigaya, and K. Wakabayashi (1990) Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia. Ann. Neurol. 28:561-567.
26. Mattson, M.P. (1994) Calcium and neuronal injury in Alzheimer's disease: Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise. Ann. N.Y Acad. Sci. 747:50-76.
27. McGeer, E.G., P.L. McGeer, H. Kamo, H. Tago, and R. Harrop (1986) Cortical metabolism, acetylcholinesterase staining and pathological changes in Alzheimer's disease. Can. J. Neurol. Sci. 13:511-156.
28. McGeer, P.L., H. Akiyama, S. Itagaki, and E.G. McGeer (1989) Immune system response in Alzheimer's disease. Can. J. Neurol. Sci. 16:516-527.
29. Morgan, K., L. Morgan, K. Carpenter, J. Lowe, L. Lam, S. Cave, J. Xuereb, C. Wischik, C. Harrington, and N.A. Kalsheker (1997) Microsatellite polymorphism of the alpha 1 antichymotrypsin gene locus associated with sporadic Alzheimer's disease. Hum. Genet. 99:27-31.
30. Mrak, R.E., J.G. Sheng, and W.S.T. Griffin (1995) Glial cytokines in Alzheimer's disease: Review and pathogenic implications. Hum. Pathol. 26:816-823.
31. Mrak, R.E., J.G. Sheng, and W.S.T. Griffin (1996) Correlation of astrocytic S100 beta expression with dystrophic neuntes in amyloid plaques of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55:273-279.
32. Nacmias, B., A. Tedde, S. Latorraca, S. Piacentini, L. Bracco, L. Amaducci, B.M. Guarnieri, C. Petruzzi, L. Ortenzi, and S. Sorbi (1996) Apolipoprotein E and alpha-1-antichymotrypsin polymorphism in Alzheimer's disease. Ann. Neural. 40:678-680.
33. Namba, Y., M. Tomoanga, H. Kawasaki, E. Otomo, and K. Ikeda (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541:163-166.
34. Perlmutter, L.S., E. Barron, D. Saperia, and H.C. Chui (1991) Association between vascular basement membrane components and the lesions of Alzheimer's disease. J. Neurosci. Res. 30:673-681.
35. Perlmutter, L.S., S.A. Scott, E. Barron, and H.C. Chui (1992) MHC class II-positive microglia in human brain: Association with Alzheimer lesions. J. Neurosci. Res. 35:549-558.
36. Randall, L.L. and S.J.S. Hardy (1989) Unity in function in the absence of consequence in sequence: Role of leader peptides in export. Science 243:1156-1159.
37. Rebeck, G.W., S.D. Harr, D.K. Strickl, and B.T. Hyman (1994) Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein receptor-related protein. Ann. Neurol. 37:211-217.
38. Rogers, J., J. Luber-Narod, S.D. Styren, and W.H. Civin (1988) Expression of immune system associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease. Neurobiol. Aging 9:339-349.
39. Roses, A.D. (1994) Apoplipoprotein E affects the rate of Alzheimer disease expression: Beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J. Neuropathol. Exp. Neurol. 53:429-437.
40. Schmechel, D.E., et. al (1993) Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90:9649-9653.
41. Sheng, J.G., R.E. Mrak, and W.S.T. Griffin (1995) Microglial interleukin-1a expression in brain regions in Alzheimer's disease: Correlation with neuritic plaque distribution. Neuropathol. Appl. Neurobiol. 21:290-301.
42. Sheng, J.S., R.E. Mrak, and W.S.T. Griffin (1996) Apolipoprotein E distribution among different plaque types in Alzheimer's disease: Implications for its role in plaque progression. Neuropathol. Appl. Neurobiol. 22:334-341.
43. Shoji, S. Hirai, H. Yamaguchi, Y. Harigaya, K. Ishiguro, and E. Matsubara (1991) Alpha 1-antichymotrypsin is present in diffuse senile plaques: Comparative study of beta-protein and alpha 1-antichymotrypsin immunostaining in the Alzheimer brain. Am. J. Pathol. 138:247-257.
44. Snow, A.D., R.T. Sekiguchi, D. Nochlin, R.N. Kalaria, and K. Kimata (1994) Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain. Am. J. Pathol. 144:337-347.
45. Strittmatter, W.J., A.M. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G.S. Salvesen, and A.D. Roses (1993) Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90:1977-1981.
46. Styren, G., W.H. Civin, and J. Rogers (1991) Quenching lipofuscin autofluorescence in aged and Alzheimer's brain: A double-label fluorescence method with Thioflavin counterstain. Soc. Neurosci. Abstr. 17:694.
47. Styren, S.D., H.W. Civin, and J. Rogers (1990) Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's diseased brain. Exp. Neurol. 110:93-104.
48. Styren, S.D., P.D. Miller, C.F. Lagenaur, and S.T. DeKosky (1994) Alternate strategies in lesion-induced reactive synaptogenesis: Differential expression of L1 in two populations of sprouting axons. Exp. Neurol. 131:165-173.
49. Tamaoka, A., N. Sawamura, A. Odaka, N. Suzuki, H. Mizusawa, S. Shoji, and H. Mori (1995) Amyloid beta protein 1-42/43 (A β1-42/43) in cerebellar diffuse plaques: Enzyme-linked immunosorbent assay and immunocytochemical study. Brain Res. 679:151-156.
50. Thome, J., A. Baumer, J. Kornhuber, M. Rosler, and P. Riederer (1995) Alpha-1-antichymotrypsin bi-allele polymorphism, apolipoprotein-E tri-allele polymorphism and genetic risk of Alzheimer's syndrome. J. Neural Transm. 10:207-212.
51. Van Eldik, L.J. and W.S. Griffin (1994) S100 beta expression in Alzheimer's disease: Relation to neuropathology in brain regions. Biochim. Biophys. Acta 1223:398-403.
52. Wertkin, A.M., R.S. Turner, S.J. Pleasure, T.E. Golde, S.G. Younkin, J.Q. Trojanowski, and V.M. Lee (1993) Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides. Proc. Natl. Acad. Sci. USA 90:9513-9517.
53. Wisniewski, T., E.M. Castano, A. Golabek, T. Volgel, and B. Frangione (1994) Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Pathol 145:1030-1035.
54. Yan, S.D., X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, A. Migheli, P. Nawroth, D. Stern, and A.M. Schmidt (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382:685-691.
55. Yoshiiwa, A., K. Kamino, H. Yamamoto, T. Kobayashi, M. Imagawa, Y. Nonomura, H. Yoneda, T. Sakai, Y. Nishiwaki, N. Sato, H. Rakugi, T. Miki, and T. Ogihara (1997) Alpha 1-antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E E4 allele carriers. Ann. Neurol. 42:115-117.